Movora appoints new co-CEO

LIGHTFIELD STUDIOS/stock.adobe.com

Movora announced Collen Flesher, its current COO, has been appointed as its new co-CEO of veterinary MedTech leader Movora, an operating company of Vimian. Beginning her duties as co-CEO today, Flesher will succeed Patrick Gendreau and Christopher Sidebotham after both decided to step down.

"I would like to sincerely thank Patrick and Chris who over the past thirty years have founded and grown two successful, leading orthopedics businesses in the US with remarkable commercial and innovation capabilities. I am thankful for their exceptional leadership throughout the integration into Vimian and the formation of Movora, today a global leader in veterinary orthopedics," says Fredrik Ullman, PhD, MScEng, MEng, BSc, CEO of Vimian Group, in an organizational release.¹

According to the release, Flesher has over 20 years of experience in leadership positions in the global MedTech sector. She worked for almost 10 years with Johnson & Johnson's MedTech divisions serving in various managerial positions within the development, innovation, marketing, product, and sales. After she left Johnson & Johnson, she served as president & general manager for Lima Corporate in the US before making her way to Movora. Flesher will lead alongside co-CEO Guy Spörri.

“Flesher is a highly appreciated leader with significant experience from the MedTech sector. With Colleen onboard, we are now ready to take the next step in our succession plans for Movora. Together with Co-CEO Guy Spörri and the rest of the leadership team in Movora, we will continue to deliver on our strategic agenda strengthening and broadening our global position in veterinary MedTech," concluded Ullman.¹

Reference

Colleen Flesher Appointed Co-CEO for Movora. News release. Movora. December 1, 2022. Accessed December 1, 2022. https://prnmedia.prnewswire.com/news-releases/colleen-flesher-appointed-co-ceo-for-movora-301690215.html